Navigation Links
DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs
Date:1/4/2012

GAITHERSBURG, Md., Jan. 4, 2012 /PRNewswire-iReach/ -- DFH Pharma, Inc., (DFH) a privately held specialty pharmaceutical company focused exclusively in the HIV-1 therapeutic space, announced today the selection of CiVentiChem, LLC to provide medicinal chemistry services to support DFH efforts to develop the next generation of HIV maturation inhibitor drugs. Maturation inhibitors are a novel class of antiretroviral drug candidates that inhibit HIV-1 replication by interfering with the maturation of the HIV-1 virus. 

The collaboration will allow DFH Pharma to expedite the discovery of 2nd generation maturation inhibitor drugs by utilizing CiVentiChem's extensive experience in the preparation and characterization of small molecule drug candidates. During 2012 DFH will work closely with CiVentiChem to extend recent successful efforts to discover new drug candidates with potent activity against all HIV strains, including those that proved resistant to the first-in-class maturation inhibitor, bevirimat. In addition to the preparation of new triterpene analogs, which form the basis for the current 2nd generation program, DFH plans to work with CiVentiChem to explore new chemical space with the goal of identifying additional classes of compounds with maturation inhibition activity.

"We are very excited to be working with CiVentiChem in the discovery of new 2nd generation HIV maturation inhibitors" said Dr. David Martin, DFH Pharma Chief Development Officer.  Dr. Martin continued, "The collaboration will allow DFH access to world-class medicinal chemists and help the Company to achieve its primary goal of returning this exciting class of HIV drug to the clinic".  Bhaskar Venepalli, Ph.D., President of CiVentiChem commented, "We are very pleased that DFH Pharma has selected CiVentiChem as its chemistry partner. We look forward to employing our va
'/>"/>

SOURCE DFH Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
(Date:5/16/2013)... 2013  Nektar Therapeutics, (Nasdaq: NKTR ) President ... , is scheduled to present at the upcoming 2013 UBS ... at the Sheraton New York Hotel on Tuesday, May 21, ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This Webcast will be available for ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, Inc. ... innovator of less invasive, miniaturized circulatory support technologies that are ... CEO Doug Godshall is scheduled to ... a.m. EDT on Monday, May 20, 2013.  The conference is ... Hotel. A live webcast of the Company,s presentation ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... May 7 Johnson & Johnson,will provide a ... 9,at 4:00 p.m. (Eastern Time) to coincide with ... Fla. Phase 3 clinical data presentations on,investigational tapentadol ... will be presented for the first time at ...
... -Large Study Shows Benefits Differ from those in ... to,children who are hospitalized for bacterial meningitis do ... hospital stays, according to a large,multicenter study by ... studies in hospitalized adults, for whom corticosteroids,dramatically reduced ...
Cached Medicine Technology:Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 2Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 3
(Date:5/19/2013)... 2013 People in Minnesota have a great ... is offering its 28 Day Fat Loss Formula. The ... comfort of their own home. The product sells for $135 ... can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season ... houses now, but after using the 28 Day Fat Loss ...
(Date:5/19/2013)... Grinding your teeth at night can ... annoying your spouse. At the same time, according to ... and Teeth Grinding Could Be a Sign of Sleep ... be hard to prevent. Apparently, Obstructive Sleep Disorder (OSD) ... its symptoms is a habit of teeth grinding along ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos is ... fat burning diet plans, training workouts, and ... package, people will receive the Fat Burning Furnace manual, ... Fat Burning Furnace manual includes fat loss knowledge, and ... In addition, this book covers step-by-step instructions, techniques and ...
(Date:5/19/2013)... 2013 The Fat Loss Code program developed ... that help people get in shape, and gain a ... The program also is a natural fat loss system that ... author of this fat loss diet program claimed that The ... help people keep body fat off long-term. After Shawn Stevenson ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Passages Malibu, ... treatment center, has announced this week the launch of ... the brands’ social media channels. “We are always ... treatment community and to get feedback regarding sobriety, what’s ... CEO and co-founder of the Passages Addiction Treatment ...
Breaking Medicine News(10 mins):Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3
... City, January 16, 2008A research team from Universit Lavals ... weight gain induced by the use of antipsychotic drugswhich ... kilos in only one monthcan be avoided through a ... psychiatrist Marie-Jose Poulin and kinesiologist Angelo Tremblay report the ...
... a precursor for pepsin, a digestive enzyme specifically produced ... into two different biochemical and immunological properties, PGI and ... the morphologic and functional changes in the stomach, and ... PG testing has been focused on the identification of ...
... receive major abdomen surgery or intestine transplantation every year ... The finding of a research group headed by Professor ... 2008 of the World Journal of Gastroenterology (volume 14, ... The study by Han Jing-Yan et al discovered Ginsenosaide ...
... FDA funding and encouraging global alliances , , , ... With every new recall of yet another staple of ... food safety problem are becoming more strident. ... U.S. Food and Drug Administration into a more powerful ...
... SPOKANE, Wash., Jan. 15 Washington Dental Service today,announced ... community.,The new facility will initially employ about 40 people, ... Eventually, the number could,expand to 70 people., "We ... in,Colville and we want to expand our operations in ...
... Care,Management Association (PCMA) issued the following statement ... the Congressional Budget Office (CBO) that,estimates the ... pharmacies:, "The new CBO analysis confirms ... increase costs for Medicare Part D, Medicaid,the ...
Cached Medicine News:Health News:Weight gain induced by antipsychotic drugs can be avoided 2Health News:What are the essential characteristics of serum PG in Chinese? 2Health News:An emerging candidate for protecting patients from liver injury after abdomen surgery 2Health News:U.S. Food Safety: A Shopping List of Solutions 2Health News:U.S. Food Safety: A Shopping List of Solutions 3Health News:U.S. Food Safety: A Shopping List of Solutions 4Health News:U.S. Food Safety: A Shopping List of Solutions 5Health News:U.S. Food Safety: A Shopping List of Solutions 6Health News:U.S. Food Safety: A Shopping List of Solutions 7Health News:Washington Dental Service Opens Larger Spokane Office 2
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... for temporary internal drainage ... to the bladder. Supplied ... Intended for one-time use. ... advised; C-Flex® and Sof-Flex® ...
... direct a .038 inch (0.97 ... a specific renal area. The ... stainless steel braid which imparts ... shaft. Supplied sterile in peel-open ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: